NCT01960946View on ClinicalTrials.gov

Galectin-3 Blockade in Patients With High Blood Pressure

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions
Hypertension
Interventions
DIETARY_SUPPLEMENT

Modified Citrus Pectin (MCP) vs placebo

5 grams by mouth three times a day

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT01960946 - Galectin-3 Blockade in Patients With High Blood Pressure | Biotech Hunter | Biotech Hunter